NEWS CENTER
Shijiazhuang Jirong Pharmaceutical Co., Ltd.
Your location:
Homepage
-
-
The scale of Asia-Pacific biopharmaceutical excipients is nearly US$800 million

The scale of Asia-Pacific biopharmaceutical excipients is nearly US$800 million

  • Categories:News
  • Author:
  • Origin:
  • Time of issue:2020-06-04
  • Views:0

(Summary description)The high investment in research and development of biosimilar drugs, as well as the successive loss of patent protection of the best-selling biologics

The scale of Asia-Pacific biopharmaceutical excipients is nearly US$800 million

(Summary description)The high investment in research and development of biosimilar drugs, as well as the successive loss of patent protection of the best-selling biologics

  • Categories:News
  • Author:
  • Origin:
  • Time of issue:2020-06-04
  • Views:0
Information
According to a new report released by the market research firm Grand View Research, in 2017, the Asia-Pacific biopharmaceutical excipient market size was approximately USD 47372 million, and it is expected to reach USD 791.4 million by 2025. During the forecast period, this market will grow at a compound annual growth rate (CAGR) of 6.63%.
The high investment in research and development of biosimilar drugs, as well as the successive loss of patent protection of the best-selling biologics, are expected to drive market development. The novel auxiliary materials increase the process output by reducing the risk of biological preparation production and promote the research of new products.

Scan the QR code to read on your phone

搜索
Search

Shijiazhuang Jirong Pharmaceutical Co., Ltd.

TEL:

ADD:

The No.8 of north of Huagong road,Circulation Chemical Industrial Zone,Shijiazhuang,Hebei,China

Copyright: © 2020 Shijiazhuang Jirong Pharmaceutical Co., Ltd.     冀ICP备20008787号-1       Powerby: 300.cn